Candelanza, Cristine M.

HRN: 14-01-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CLINDAMYCIN 300MG (CAP)
09/18/2025
09/24/2025
PO
300mg
TID
SP Pelvic Lap With BTL
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines